USFDA Inspection Close-out of Bio-Analytical Laboratory, Unit 7, Shilpa Medicare Limited, Nacharam, Hyderabad, Telangana

The Bio Analytical Laboratory, Shilpa Medicare Limited, Unit 7, Nacharam, Hyderabad, India was inspected by USFDA from 26th February to 1st March 2024. The inspection was concluded with zero 483 observations and no discussion items.

The Agency has concluded that this inspection has now been closed with the issuance of the Establishment Inspection Report (EIR). The facility is classified as "No Action Indicated" (NAI).

This Unit of Shilpa Medicare is engaged in testing biological samples of clinical studies and BA/BE studies in human subjects as per global regulatory requirements. This is a newly set up Centre for bio-analytical testing and this is the first regulatory inspection and approval for this Site from USFDA.

This facility is approved by EMA, Europe.

Shares of Shilpa Medicare Limited was last trading in BSE at Rs. 589.95 as compared to the previous close of Rs. 595.85. The total number of shares traded during the day was 35626 in over 2748 trades.

The stock hit an intraday high of Rs. 607.15 and intraday low of 577.25. The net turnover during the day was Rs. 21160346.00.

Source : Equity Bulls

Keywords

ShilpaMedicare INE790G01031 BioAnalyticalLaboratory USFDA Inspection EIR